Clinical approach to inherited metabolic disorders in neonates: an overview
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Neonatology
- Vol. 7 (1) , 3-15
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Mutations in the 3β-Hydroxysterol Δ24-Reductase Gene Cause Desmosterolosis, an Autosomal Recessive Disorder of Cholesterol BiosynthesisThe American Journal of Human Genetics, 2001
- Mutations in the NSDHL gene, encoding a 3?-hydroxysteroid dehydrogenase, cause CHILD syndromeAmerican Journal of Medical Genetics, 2000
- Inborn Errors of Cholesterol BiosynthesisAdvances in Pediatrics, 2000
- Arrhythmias and Conduction Defects as Presenting Symptoms of Fatty Acid Oxidation Disorders in ChildrenCirculation, 1999
- Recognition and management of fatty acid oxidation defects: A series of 107 patientsJournal of Inherited Metabolic Disease, 1999
- Phosphomannose Isomerase Deficiency: A Carbohydrate-Deficient Glycoprotein Syndrome with Hepatic-Intestinal PresentationThe American Journal of Human Genetics, 1998
- Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.Journal of Clinical Investigation, 1998
- Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduriaThe Lancet, 1998
- Metabolic intermediates in lactic acidosis: compounds, samples and interpretationJournal of Inherited Metabolic Disease, 1996